Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.

[1]  Marc M Cohen,et al.  Garlic for the common cold. , 2014, The Cochrane database of systematic reviews.

[2]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[3]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[4]  D. Yealy,et al.  Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review. , 2012, Annals of emergency medicine.

[5]  O. Dekkers,et al.  Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis , 2012, European Respiratory Journal.

[6]  W. Ageno,et al.  Prognostic clinical prediction rules to identify a low‐risk pulmonary embolism: a systematic review and meta‐analysis , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[8]  T. Fujita.  Outpatient treatment for pulmonary embolism , 2011, The Lancet.

[9]  Nathan A. Pugh,et al.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial , 2011, The Lancet.

[10]  A. Ruppert,et al.  Economic burden of venous thromboembolism: a systematic review , 2011, Journal of medical economics.

[11]  O. Dekkers,et al.  Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study , 2011, Journal of thrombosis and haemostasis : JTH.

[12]  T. Baglin.  Fifty per cent of patients with pulmonary embolism can be treated as outpatients , 2010, Journal of thrombosis and haemostasis : JTH.

[13]  M. Prins,et al.  Safety of outpatient treatment in acute pulmonary embolism , 2010, Journal of thrombosis and haemostasis : JTH.

[14]  M. Kovacs,et al.  Ambulatory management of pulmonary embolism: a pragmatic evaluation , 2010, Journal of thrombosis and haemostasis : JTH.

[15]  D. Aujesky,et al.  Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry. , 2010, European journal of internal medicine.

[16]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[17]  D. Jiménez,et al.  Home treatment in pulmonary embolism. , 2010, Thrombosis research.

[18]  M. Prins,et al.  Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level , 2010, Journal of thrombosis and haemostasis : JTH.

[19]  P. Wells,et al.  Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism , 2010, Annals of Internal Medicine.

[20]  D Bergqvist,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.

[21]  G. Moneta.  Recent Trends in Clinical Outcomes and Resource Utilization for Pulmonary Embolism in the United States: Findings From the Nationwide Inpatient Sample , 2010 .

[22]  F. Anderson,et al.  Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. , 2009, Chest.

[23]  A. Fernandez-cruz,et al.  A prospective study of the management of non-massive pulmonary embolism in the home. , 2009, European journal of internal medicine.

[24]  W. Ageno,et al.  Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review , 2009, European Respiratory Journal.

[25]  P. Stein,et al.  Treatment of acute pulmonary embolism as outpatients or following early discharge , 2008, Thrombosis and Haemostasis.

[26]  R. Yusen,et al.  Short-term clinical outcome after acute symptomatic pulmonary embolism , 2008, Thrombosis and Haemostasis.

[27]  Piotr Pruszczyk,et al.  Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .

[28]  J. Wimperis,et al.  Early discharge of patients with pulmonary embolism: a two-phase observational study , 2007, European Respiratory Journal.

[29]  G. Raskob,et al.  Idraparinux versus standard therapy for venous thromboembolic disease. , 2007, The New England journal of medicine.

[30]  C. Kearon.  Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolism Kearon C, Ginsberg JS, Julian JA, et al. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of ve , 2007 .

[31]  B. Jonson,et al.  Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[32]  J. Douketis,et al.  Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. , 2006, JAMA.

[33]  G. Wells,et al.  A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. , 2005, Archives of internal medicine.

[34]  M. Valerio,et al.  Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[36]  M. Prins,et al.  Once versus twice daily LMWH for the initial treatment of venous thromboembolism. , 2002, The Cochrane database of systematic reviews.

[37]  E. Ramacciotti,et al.  An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. , 2004, Thrombosis research.

[38]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. , 2004, The Cochrane database of systematic reviews.

[39]  J. Beer,et al.  Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1 , 2003, Journal of thrombosis and haemostasis : JTH.

[40]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[41]  M. Prins,et al.  Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. , 2002, The Cochrane database of systematic reviews.

[42]  J. M. Tenías,et al.  Home treatment of deep venous thrombosis with low molecular weight heparin: Long‐term incidence of recurrent venous thromboembolism , 2001, American journal of hematology.

[43]  M Gent,et al.  Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  M. Kovacs,et al.  Outpatient Treatment of Pulmonary Embolism with Dalteparin , 2000, Thrombosis and Haemostasis.

[45]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. , 2000, The Cochrane database of systematic reviews.

[46]  P. Wells,et al.  Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. , 1998, Archives of internal medicine.

[47]  S D Small,et al.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.

[48]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[49]  P. Bossuyt,et al.  The clinical course of patients with suspected pulmonary embolism. , 1997, Archives of internal medicine.

[50]  P. Bossuyt,et al.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. , 1996, The New England journal of medicine.

[51]  J. Hirsh,et al.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. , 1996, The New England journal of medicine.

[52]  M. Vigotti,et al.  [Short-term prognosis of pulmonary embolism]. , 1988, Giornale italiano di cardiologia.